Bank of America’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Bank of America’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-29,358	Closed	-$3K	–	7679
2016 Q3	$3K	Sell	29,358 -1,308	-4%	-$285	﹤0.01%	6786
2016 Q2	$11K	Buy	30,666 +1,820	+6%	+$692	﹤0.01%	6475
2016 Q1	$11K	Buy	28,846 +436	+2%	+$180	﹤0.01%	6379
2015 Q4	$11K	Sell	28,410 -3,730	-12%	-$1.77K	﹤0.01%	6666
2015 Q3	$18K	Hold	32,140	–	–	﹤0.01%	6356
2015 Q2	$17K	Buy	32,140 +1,880	+6%	+$1.53K	﹤0.01%	6409
2015 Q1	$25K	Buy	30,260 +14,600	+93%	+$12K	﹤0.01%	5965
2014 Q4	$13K	Hold	15,660	–	–	﹤0.01%	6981
2014 Q3	$16K	Buy	15,660 +5,130	+49%	+$4.97K	﹤0.01%	7157
2014 Q2	$9K	Buy	+10,530	New	+$12.6K	﹤0.01%	7516

Other funds holding PVCT

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

Bank of America's PVCT Position: Q4 2016 in Review

Bank of America sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 29,358 shares — an estimated $3K sold.

Bank of America first reported a position in PVCT in Q2 2014 and held it in 10 quarters. The position peaked at $25K in Q1 2015. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

Bank of America reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
Bank of America sold 29,358 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $3K.
Bank of America first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and held it in 10 quarters.
Bank of America's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $25K in Q1 2015.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Bank of America's 13F filing for Q4 2016, filed 14 Feb 2017.